Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion

Steven J Ryder1 Department of Ophthalmology, Weill Cornell Medical College, New York, NY, USACorrespondence[email protected]

Danilo Iannetta1 Department of Ophthalmology, Weill Cornell Medical College, New York, NY, USA

Swetangi D Bhaleeya2 Department of Ophthalmology, University of South Florida, Tampa, FL, USA

Szilárd Kiss1 Department of Ophthalmology, Weill Cornell Medical College, New York, NY, USA

Pages 1109-1116 | Published online: 23 Jun 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

KapoorKGWagnerMGWagnerALThe Sustained-Release Dexamethasone Implant: Expanding Indications in Vitreoretinal DiseaseSemin Ophthalmol Epub2014321
Web of Science ®Google Scholar
ComynOLightmanSLHykinPGCorticosteroid intravitreal implants vs ranibizumab for the treatment of vitreoretinal diseaseCurr Opin Ophthalmol20132424825423518614
PubMed Web of Science ®Google Scholar
CallananDGJaffeGJMartinDFPearsonPAComstockTLTreatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial resultsArch Ophthalmol20081261191120118779477
PubMed Web of Science ®Google Scholar
KaneFEBurdanJCutinoAGreenKEIluvien: a new sustained delivery technology for posterior eye diseaseExpert Opin Drug Deliv200851039104618754752
PubMed Web of Science ®Google Scholar
WilliamsGAHallerJAKuppermanBDDexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndromeAm J Ophthalmol20091471048105419268890
PubMed Web of Science ®Google Scholar
HallerJAKuppermanBDBlumenkranzMSRandomized controlled trial of intravitreous dexamethasone drug delivery system in patients with diabetic macular edemaArch Ophthalmol201012828929620212197
PubMed Web of Science ®Google Scholar
HallerJABandelloFBelfortRJrOZURDEX GENEVA Study GroupRandomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionOphthalmology20101171134114620417567
PubMed Web of Science ®Google Scholar
US Food and Drug AdministrationOzurdex®: Highlights of Prescribing InformationSilver SpringUS Food and Drug Administration2014 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022315s010lbl.pdfAccessed January 17, 2015
Google Scholar
LowderCBelfortRJrLightmanSOzurdex HURON Study GroupDexamethasone intravitreal implant for noninfectious intermediate or posterior uveitisArch Ophthalmol2011129554555321220619
PubMed Web of Science ®Google Scholar
Tomkins-NetzerOTaylorSRBarATreatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitisOphthalmology201412181649165424650556
PubMed Web of Science ®Google Scholar
LatronicoMERiganteDCasoFBilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitisClin Rheumatol Epub2014425
Web of Science ®Google Scholar
SaatciAOSelverOBSeymenogluGYamanABilateral intravitreal dexamethasone implant for retinitis pigmentosa-related macular edemaCase Rep Ophthalmol201341535823616764
PubMedGoogle Scholar
SharmaAShethJMadhusudanRJSundaramoorthySKEffect of intravitreal dexamethasone implant on the contralateral eye: a case reportRetin Cases Brief Rep20137321721925391109
PubMedGoogle Scholar
KiernanDFMielerWFThe use of intraocular corticosteroidsExpert Opin Pharmacother200910152511252519761356
PubMed Web of Science ®Google Scholar
DriotJYNovackGDRittenhouseKDMilazzoCPearsonPAOcular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year periodJ Ocul Pharmacol Ther20042026927515279731
PubMed Web of Science ®Google Scholar
GoldsteinDAGodfreyDGHallAIntraocular pressure in patients with uveitis treated with fluocinolone acetonide implantsArch Ophthalmol20071251478148517923537
PubMed Web of Science ®Google Scholar
HallerJABandelloFBelfortRJrDexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study resultsOphthalmology2011118122453246021764136
PubMed Web of Science ®Google Scholar
KhuranaRNAppaSNMcCannelCADexamethasone implant anterior chamber migration: risk factors, complications, and management strategiesOphthalmology20141211677123890421
PubMed Web of Science ®Google Scholar
BakriSJRiscoMEdwardsAOPulidoJSBilateral simultaneous intravitreal injections in the office settingAm J Ophthalmol20091481666919403114
PubMed Web of Science ®Google Scholar
MonteroJARuiz-MorenoJMIntravitreal inserts of steroids to treat diabetic macular edemaCurr Diabetes Rev200951263219199895
PubMedGoogle Scholar
CaoJHMulvahillMZhangLJoondephBCDaceyMSDexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammationOphthalmology20141211871187624907061
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date